Background: The aim of this study was to compare the effectiveness and duration of action of two concentrations of bupivacaine with adrenaline for postoperative pain in patients undergoing surgical removal of four third molars under general anesthesia. Methods: Sixty patients undergoing surgical removal of four wisdom teeth received bupivacaine 0.5% (n = 30) or 0.25% (n = 30). The severity of pain in the immediate recovery period and at 2 and 24 h after surgery was recorded using the visual analogue scale. Differences were assessed by box and whisper plot and the Student's t-test. Results: The analgesic effects of the 0.25% and 0.5% doses were significantly different (P = 0.022) at 30 min after surgery but not after 2 and 24 h. The difference of mean of 0.25% and 0.5% was much higher after 0.5 h but less after 2 and 24 h. Conclusions: Bupivacaine 0.5% was statistically better for pain control during the immediate postoperative period, but there was no significant difference in pain control between the two dose strengths at 2 and 24 h after surgery.
INTRODUCTION
Pain is an unpleasant sensation that humans try to avoid. Management of pain has been of the utmost interest in the field of medicine since ancient times, particularly in dentistry. Today, there are many potent, long-acting, local anesthetic agents available to achieve satisfactory pain control during and after dental surgery.
Third molar extraction has proven to be a suitable model for randomized controlled trials comparing different pain control agents [1] .
A variety of local anesthetics has been developed to satisfy the specific requirements for different clinical procedures. Bupivacaine is often chosen for prolonged surgical procedures, such as removal of four wisdom teeth, due to its extended duration of anesthetic action [2] . Moreover, some authors have credited bupivacaine with the ability to achieve longer postoperative analgesia and to reduce analgesic requirements in the early postoperative hours when pain intensity is at its maximum. This feature is important given that postoperative pain is one of the main concerns for patients when undergoing a surgical procedure.
Bupivacaine is a common choice for pain control after removal of wisdom teeth. One of the amide group of local anesthetic agents, bupivacaine is marketed in several concentrations, the most common of which are 0.5% with 1:200,000 adrenaline and 0.25% with 1:400,00 adrenaline [3] [4] [5] [6] . Although bupivacaine has been used for a long time, there have been very few comparative studies assessing its analgesic efficacy at different concentrations [7] [8] [9] .
The aim of this study was to compare the effectiveness and duration of action of two concentrations of bupivacaine commonly used in combination with adrenaline for pain control after surgical removal of four wisdom teeth under general anesthesia.
MATERIALS AND METHODS
Sixty cases were calculated to be a reasonable sample size for a pilot study. Removal of four wisdom teeth under 
RESULTS
Four patients from the bupivacaine 0.25% group were lost to follow-up at 24 h. In the immediate postoperative recovery period, patients in the bupivacaine 0.5% group required marginally less supplemental analgesia than those in the bupivacaine 0.25% group (Table 1) F  83  69  60  17  0  0  21  22  26  F  M  90  75  28  41  100  0  22  23  16  F  F  53  55  10  53  0  0  23  34  20  F  M  56  57  35  36  0  0  24  29  29  M  F  71  100  22  60  0  0  25  42  33  F  M  70  71  18  25  100  0  26  17  20  F  M  67  85  24  40  80  0  27 - ference in mean patient age or duration of surgery between the groups, although the 0.5% group had a slightly longer operative time (Table 2) . Similarly, there was no statistically significant difference in pain intensity at 24 h postoperatively.
The results of this study suggest the higher concentration of bupivacaine 0.5% provides better analgesia than the lower concentration of 0.25% (Fig. 1) .
The box and whisker plot shows the 25th quartile, the median quartile (50th), and 75th quartile. When the spread among the 25th, 50th and 75th quartiles is less, the sample has less variance. This method is also used to reduce the impact of outliers in an analysis. In this study, spread among the 25th and 75th quartiles for bupivacaine 0.5% was less than that for bupivacaine 0.25% (Fig. 1) .
In addition to the box and whisker plot, the Student's t-test was used to test for a statistically significant difference in ability to control pain between the 0.25% and 0.5% doses of bupivacaine. The Student's t-test is commonly used in medical research to check for statistically significant differences in effect between drug doses (Maeda et al, 2002 ) [10] . The Student's t-test is a tool for testing the null hypothesis where the means of two samples are equal and gives the probability that this is the case. If this probability is less than 0.05, the null hypothesis is rejected and the two samples are deemed to be significantly different (Table 1) . When the P-value is less than 0.05, the difference in effect between two different doses is significant.
Therefore, the analgesic effects of the 0.25% and 0.5% doses were significantly different (P = 0.022) at 30 min after surgery but not after 2 and 24 h. The difference in the mean VAS scores for 0.25% and 0.5% was much higher after 0.5 h but less after 2 and 24 h (Fig. 2) . There are no comparative studies of two concentrations of bupivacaine reported in the literature especially in cases of wisdom teeth removal under general anesthesia [5, 6] .
DISCUSSION
Published comparisons of carbonated bupivacaine with adrenaline and noncarbonated bupivacaine with adrenaline have reported a significant difference in time to onset of anesthesia; however, this study was performed under local anesthesia and not all the wisdom teeth were removed [9] . A carbonated formulation would be difficult to use in Australia given that such products need regulatory approval and must be supplied in prepackaged vials.
In the present study, the efficacy of bupivacaine 0.5% and 0.25% with adrenaline was evaluated for its ability to reduce postoperative pain at three time points.
Significant differences were observed in the immediate postoperative recovery period; patients who received bupivacaine 0.5% required less supplemental analgesia during this time (Fig. 1) . This finding justifies the use of an increased concentration of bupivacaine.
It is often difficult to differentiate between anesthesia and pain until the patient is fully conscious and oriented [7] [8] [9] . In this study, the intensity of pain was similar in both the groups after 2 and 24 h, suggesting that patients were fully awake and oriented and could differentiate pain from anesthesia.
There was no difference in mean patient age between the two groups. There were more women in the bupivacaine 0.5% group and more men in the bupivacaine 0.25% group. While comparing body weight between the two groups, the bupivacaine 0.25% group was heavier and the operating time was slightly longer in the 
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